1Williams KJ,Tabas I.The response-to-retention hypothesis of atherogenesis reinforced.Curr Opin Lipidol,1998,9:471-474.
2Camejo G,Hurt-Camejo E,Wiklund O,et al.Association of apo B lipoproteins with arterial proteoglycans:pathological significance and molecular basis.Atherosclerosis,1998,139:205-222.
3Brown MS,Goldstein JL.A receptor-mediated pathway for cholesterol homeostasis.Science,1986,232:34-47.
4Ishibashi S,Goldstein JL,Brown MS,et al.Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptornegative mice.J Clin Invest,1994,93:1885-1893.
5Vrablik M,Ceska R,Horinek A.Major apolipoprotein B-100mutations in lipoprotein metabolism and atherosclerosis.Physiol Res,2001,50:337-343.
6Packard CJ.Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism.Curr Opin Lipidol,1999,10:237-244.
7Schonfeld G.Genetic variation of apolipoprotein B can produce both low and high levels of apoB-containing lipoproteins in plasma.Can J Cardiol,1995,11 Suppl G:86G-92G.
8Olofsson SO,Asp L,Boren J.The assembly and secretion of apolipoprotein B-containing lipoproteins.Curr Opin Lipidol,1999,10:341-346.
9Segrest JP,Jones MK,De Loof H,et al.Structure of apoolipoprotein B-100 in low density lipoproteins.J Lipid Res,2001,42:1346-1367.
10Bakillah A,Jamil H,Hussain MM.Lysine and arginine residues in the N-terminal 18% of apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.Biochemistry,1998,37:3727-3734.
8Nancy F Butte. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus [ J ]. Am J Clin Nutr ,2000,71 (SSuppl) : 1256 - 1261.
9Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression [ J ]. J Postgrad Med, 2001,109 ( 4 ) : 55 -91.
10Wang Y,Oram JF.Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1.J Biol Chem,2002,277:5692-5697.
